P672: REAL-LIFE EFFICACY AND SAFETY OF VENETOCLAX MONOTHERAPY IN RELAPSED/ REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA - INTERIM ANALYSIS OF MULTICENTRIC STUDY VERONE

• L. Ysebaert,
• X. Troussard,
• V. Levy,
• R. Le Calloch,
• R. Guieze,
• S. Leprêtre,
• A.-S. Michallet,
• V. Leblond,
• P. Feugier,
• J. Ramier,
• A. Delmer

Affiliations

L. Ysebaert

1 Hematology Unit, IUCT Oncopole, Toulouse

X. Troussard

2 Hematology Unit, CHU Caen, Caen

V. Levy

3 Hematology Unit, Hopital Avicenne, Bobigny

R. Le Calloch

4 Hematology Unit, CH Cornouaille, Quimper

R. Guieze

5 Hematology Unit, CHU Clermont-Ferrand, Clermont-Ferrand

S. Leprêtre

6 Hematology Unit, Henri Becquerel Cancer Research Center, Rouen

A.-S. Michallet

7 Hematology Unit, Leon Berard Cancer Reseach Center, Lyon

V. Leblond

8 Hematology Unit, Hôpital Pitié-Salpêtrière, Paris

P. Feugier

9 Hematology Unit, CHRU Nancy, Nancy

J. Ramier

10 AbbVie France, Rungis

A. Delmer

11 Hematology Unit, CHU Reims, Reims, France